Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma: A Phase 2 Clinical Trial

IMPORTANCE: Gemcitabine with platinum has limited efficacy for treatment of advanced cholangiocarcinoma, necessitating an evaluation of alternative drug combinations. Recent evidence suggests that paclitaxel may potentiate gemcitabine activity. OBJECTIVE: To evaluate whether gemcitabine plus nanopar...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Oncol
Autors principals: Sahai, Vaibhav, Catalano, Paul J., Zalupski, Mark M., Lubner, Sam Joseph, Menge, Mark R., Nimeiri, Halla Sayed, Munshi, Hidayatullah G., Benson, Al Bowen, O’Dwyer, Peter J.
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2018
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6440720/
https://ncbi.nlm.nih.gov/pubmed/30178032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2018.3277
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars